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Coppenolle et al. (2001) reported hyperprolactinemia 
induced hyperplasia associated with inflammation in 
the rat lateral prostate lobe after treatments for 30 and 
60 days with sulpiride.  
The period prior to rat puberty, from the 15th to the 
25th postnatal day, has been acknowledged as being 
critical to prostatic development. In this period, plasma 
PRL levels begin to rise, reaching the highest point 
on the 25th day of postnatal development (NEGRO-
The role of prolactin in prostatic inflammation
O papel da prolactina na inflamação prostática
Edson João da SILVA1; Maria Lúcia ZAIDAN-DAGLI1; Antonia Gladys NASELLO2; 
Janete Aparecida ANSELMO-FRANCI3; Luciano Freitas FELICIO1
1 Departamento de Patologia da Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo, São Paulo – SP, Brasil
2 Departamento de Ciências Fisiológicas da Faculdade de Ciências Médicas da Santa Casa, São Paulo – SP, Brasil
3 Departamento de Fisiologia da Faculdade de Odontologia de Ribeirão Preto da Universidade de São Paulo – SP, Brasil
Correspondence to: 
Luciano Freitas Felicio
Departamento de Patologia. Faculdade de Medicina Veterinária e Zootecnia – 
Universidade de São Paulo
Avenida Professor Doutor Orlando Marques de Paiva, 87. Cidade Universitária





Prolactin (PRL) modulates various aspects of 
male physiology (CRUZ-CASALLAS et al., 1999; 
SILVA et al., 2004). It has been established that PRL 
stimulates prostate growth and functioning in both 
young and adult rats (KEENAN; KLASE; THOMAS, 
1981; NEGRO-VILAR; KRULICH; McCANN, 1973; 
PRINS; LEE, 1983). Moreover, inflammation in 
lateral prostate seems to be related to high serum PRL 
levels (STOKER; ROBINETTE; COOPER, 1999). 
High plasma PRL levels throughout newborn or 
prepubescent periods result in an increased incidence 
of prostatic inflammation in adult rats (STOKER et 
al., 1999). A causal relationship has been suggested 
between prostatic inflammation and benign prostatic 
hyperplasia in humans (GILLERAN et al., 2003). 
Abstract 
Several reports have shown that prolactin (PRL) plays a role in prostatic growth, but few studies considered the role 
of PRL in the process of prostatic inflammation. Young (45 ± 5 days old) and adult (75 ± 5 days old) male Wistar rats 
were subcutaneously injected daily with domperidone (4.0 mg.kg-1) to maintain high serum PRL levels. The animals 
were treated for 15, 30, 45 or 60 days. Blood and prostate samples were collected at the end of each treatment for PRL 
dosage and histological analysis, respectively. Only young animals treated with DOMP for 15 and 30 days displayed 
inflammatory infiltrate in the prostate. These results confirm literature data in regards to PRL involvement in inducing 
prostate inflammation. Moreover, it was concluded that young animals are more susceptible then adults to the PRL 
action concerning prostate inflammation.
Keywords: Hyperprolactinemia. Domperidone. Prostate. Rats.
Resumo
A prolactina (PRL) influencia o crescimento prostático, entretanto poucos estudos investigaram o papel da PRL na 
inflamação prostática. Ratos Wistar jovens (45 ± 5 dias de idade) e adultos (75 ± 5 dias de idade) receberam injeções 
subcutâneas diárias de domperidona (4,0 mg.kg-1) para manter níveis séricos altos de PRL. Os animais foram tratados 
por 15, 30, 45 ou 60 dias. Amostras de sangue e próstata foram coletadas ao final dos tratamentos para dosagem de 
PRL e análise histológica, respectivamente. Apenas os animais jovens tratados com domperidona por 15 e 30 dias 
apresentaram infiltrado inflamatório na próstata. Esses resultados confirmaram a participação da PRL na indução da 
inflamação prostática. A conclusão obtida foi que animais jovens são mais susceptíveis à ação da PRL na inflamação da 
próstata que os adultos.       
Palavras-chave: Hiperprolactinemia. Domperidona. Próstata. Ratos. 
469
Braz. J. Vet. Res. Anim. Sci., São Paulo, v. 50, n. 6, p. 468-473, 2013
VILAR; KRULICH; McCANN, 1973). Prostates from 
immature rats display higher binding to PRL than that 
observed in adult animals (ARAGONA; FRIESEN, 
1975).
In addition, various reports have emphasized 
that PRL plays a role in prostatic growth.  Prolactin 
promotes a receptor mediated up-regulation of the 
L-aspartate transporter EAAC1, which is involved 
in mechanisms of hormonal regulation controlling 
the cellular environment (FRANKLIN et al., 2006). 
Prolactin also increases vitamin D receptor and p21 
through up-regulation of short 1b prolactin receptor 
in human prostate cancer cells (WU et al., 2005).
This study was designed to investigate the age-
related differences in the pharmacologically-
induced increase in serum PRL levels as well as their 
influence on the spontaneous induction of prostatic 
inflammation. For this purpose, young and adult 
individuals were compared.
         
Material and Methods
Previous works have demonstrated that treatment 
with domperidone (DOMP, 4.0 mg.kg-1) was able to 
increase PRL secretion and this effect lasted for about 
72 hours (FELICIO; BRIDGES, 1992; NASELLO et 
al., 1995; NASELLO et al., 1997; SILVA et al., 2004). 
A total of 139 male Wistar rats from the colony of the 
FMVZ/USP were used: 68 young (45 ± 5 days old) 
and 71 adult rats (75 ± 5 days old) in order to evaluate 
the effects of DOMP-induced hyperprolactinemia on 
the induction of prostatic inflammation. The animals 
received free access to water and food and were 
maintained in a 12:12 hour light:dark cycle. They 
were separated into two major groups: experimental 
(treated with DOMP 4.0 mg.kg-1, sc, daily) and 
control (saline/SAL). Animals were treated for 15, 30, 
45 or 60 days. Animals were decapitated at the end 
of each treatment with a minimum of stress. Blood 
and prostate samples were collected for prolactin 
dosage by radioimmunoassay and histological 
analysis, respectively. The animals used in this study 
were maintained in accordance with the guidelines 
from the Committee on Care and Use of Laboratory 
Animal Resources, National Research Council, USA.  
Blood was collected into a test tube and kept 
at room temperature until a clot was formed. If 
necessary, the blood was centrifuged for serum 
separation. Once serum was obtained, it was stored in 
duplicate in polyethylene tubes (eppendorfs) and kept 
at -80oC until hormonal dosage. PRL concentration 
was obtained by means of radioimmunoassay with 
double antibody, by using specific kits supplied by 
The National Institute of Diabetes and Digestive and 
Kidney Diseases (NIADDK, Baltimore, MD, USA). 
Antiserum anti-rat PRL-S9 for PRL was used and 
reference preparations were PRL-RP3. The lower 
limit of detection was 0.19 ng.mL-1 and coefficients of 
variation intra and inter assay were 4.0% and 11.5%, 
respectively.  PRL levels are expressed in ng.mL-1.  
After dissection, prostate samples were fixed into 
Bouin’s solution for approximately 48 hours. Samples 
were transferred to alcohol 70% for routine paraffin 
embedding. The 5 mm sections were stained with 
hematoxylin and eosin (HE) for histological analysis. 
Statistical analysis
Serum PRL concentrations were compared by 
Mann-Whitney U-test. Qualitative data specific to 
prostate histological alterations were analyzed by 
Exact test of Fisher. In both cases, P < 0.05 values, 
obtained using two-tailed comparisons, were 
considered statistically significant.
Results
Serum PRL levels increased significantly throughout 
the treatment in both young and adult animals treated 
with DOMP, except young animals treated for 45 days 
(Figure 1). Tables 1 and 2 show data from the prostates 
of young and adult animals, respectively. Young 
animals treated with DOMP displayed an intense 
multifocal inflammatory infiltrate in the lumen of 
prostatic acini, and, sometimes, an inflammatory 
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Figure 1 – Serum levels of PRL (ng/ml), in young (Figure 1A) and adult animals (Figure 
1B), respectively, treated with DOMP and controls (SAL).  Data are median 
and individual values. 
          * P < 0.05 compared to respective control groups
Table 1 -  Eff ect of DOMP (4.0 mg.kg-1) on the incidence of prostatitis in young rats. 
Th e number of animals with lesions over the total number of animals per 
group is presented
                                                                                      Period of treatment (days)
Groups  15 30 45 60
SAL 2/10  0/8  4 /8 0/7 
DOMP 7/10  8/8  6/8  4/8 
Degree of signifi cance P < 0.05 P < 0.0001 P = 0.30 P < 0.052
Statistical analyses Fisher Exact test 
Table 2 -  Eff ect of DOMP (4.0 mg.kg-1) on adult animals presenting prostate changes 
such as prostatitis or cell desquamation. Numbers shown are of animals 
presenting prostate changes from total number of animals in group
                          Period of treatment (days)
Groups  15 30 45 60
SAL 1/7  1/8  2/6  2/8 
DOMP 3/8  6/10  6/7  5/9 
Degree of signifi cance  P = 0.34 P = 0.07 P = 0.10 P = 0.22
Statistical analyses Fisher Exact test
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infiltrate in connective tissue was noted (Table 1 
and Figure 2). In respect to the type of cell found 
in the inflammatory infiltrate, polymorphonuclear 
(neutrophils) and mononuclear cells (lymphocytes) 
were found. The adult animals treated with DOMP 
showed no significant histological changes in any 
treatment day (Table 2).   
Discussion 
Consistent with literature data, animals treated 
with DOMP showed higher serum PRL levels than 
saline-treated rats. Nevertheless, DOMP-induced 
hyperprolactinemia seems to be more intense in adult 
than in young animals. These data show that when 
challenged with DOMP, young animals release PRL 
to a lesser extent than the adults.
Figure 2 – Histological aspects of lateral prostate lobe of 
young animal of SAL (Figure 2A) and DOMP 
(Figure 2B) groups. Stained with hematoxylin 
and eosin (HE) magnification X100. Arrow in 
figure 2B shows leukocyte infiltrate
It has been demonstrated that an increase in 
serum PRL levels is a potent stimulus in inducing 
and maintaining inflammatory reaction in the 
lateral prostate in rats. Moreover, some studies have 
suggested that there is an association between prostate 
inflammation and prostate hyperplasia (KESSLER et 
al., 1998). Prostate inflammation has been commonly 
noted in samples of human prostate that have shown 
benign prostate hyperplasia (STOKER et al., 1999). 
Tangbanluekal and Robinette (1993) have observed 
that estradiol-induced hyperprolactinemia as well 
PRL itself can stimulate inflammation in the lateral 
prostate lobe in adult rats. They observed that the 
hyperprolactinemic animals showed leukocyte 
infiltrates in the lumen of prostate acini, neutrophils, 
and mononuclear leukocytes in the stroma. They also 
observed that the higher the PRL dose administered, 
the greater the inflammatory process. A similar result 
was found by Stoker et al. (1999). These authors have 
suggested that PRL plays a role in this process. Stoker 
et al. (1999) have demonstrated that 15-20 day old 
Wistar rats exposed to compounds stimulating PRL 
secretion such as 17b-estradiol, pimozide or bisphenol 
A presented inflammation in the lateral prostate lobe 
at 120 days of adulthood.  Prostate inflammation has 
also been observed in Noble adult rats (11-12 weeks 
old) when treated with 17b-estradiol for 56 days 
(LANE et al., 1997). Transgenic mice expressing one 
specific prostatic gene linked to the PRL rat gene show 
inflammation, infiltrating the prostate (KINDBLOM 
et al., 2003). In this model, these authors have 
demonstrated that a local increase of PRL in the 
prostate is capable of inducing prostatic changes such 
as inflammatory cell accumulation, an increase in the 
stroma and prostate duct dilatation, which are basic 
features of benign prostatic hyperplasia in humans. 
In the present work using DOMP to maintain high 
levels of serum PRL, we observed in the inflammatory 
infiltrate polymorphonuclear cells (neutrophils) and 
mononuclear cells (lymphocytes) in the prostate. 
We also observed that the polymorphonuclear cells 
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prevailed in the lumen of prostate acinus, while the 
mononuclear cells prevailed in the gland stroma. 
Regarding the degree of inflammation, the presence 
of inflammatory cells was more severe in the lumen of 
the prostate gland.
In a retrospective analysis, Suwa et al. (2001) 
reported a significant positive correlation between 
pituitary adenoma and inflammation dorsolateral 
prostate lobe in Fischer-344 rats. These authors have 
suggested that PRL, which has been produced in 
excess by pituitary adenoma, could be a predisposing 
factor in prostate dorsolateral lobe inflammation.
In spite of several works clearly demonstrating 
the role of PRL in prostate inflammation process, it 
is not clear how PRL induces such a response. It is 
known that lymphocytes have receptors for PRL 
(PELLEGRINI et al., 1992) and PRL is mitogenic for 
T-cells proliferation as well as an inducer for cytokines 
and antibody production (CLEVENGER; FREIER; 
KLINE, 1998; McMURRAY, 2001). Thus, these are 
possible mechanisms for PRL involvement in prostate 
inflammatory process.  
Since we have noted no differences between serum 
PRL levels in young animals treated with DOMP for 
15 and 30 days, there might be other inflammatory 
factors in young animals besides the increase in 
serum PRL levels. One such factor would be the 
extent of the period of treatment. Alternatively, the 
lack of finding a significant difference in prolactin at 
45 days in the younger animals may have been due 
to the variation of prolactin levels in the control rats. 
On the other hand, there were no significant prostate 
changes in adult animals treated with DOMP for 
the same period in spite of the increased serum PRL 
levels observed in these animals. Since lymphocytes 
located in inflamed prostates have shown PRL-like 
transcripts, it has been suggested that a PRL-like 
substance produced locally could contribute to 
maintaining serum PRL-induced lateral prostate 
inflammation in rats. Therefore, a locally prostate 
produced PRL may play a role in inflammatory cell 
infiltrate (ROBINETTE; TREMPUS; ONKS, 1993). 
Alternatively, the possibility that DOMP itself has 
direct inflammatory effects on the prostate cannot 
be discharged. The possibility that DOMP stimulates 
local production of prolactin in the prostate before it 
increases pituitary prolactin production and which 
may give rise to the inflammation seen early in the 
younger rats has to be investigated in future studies. If 
that would be the case, it would still be in accordance 
with the general concept of a higher sensitivity of 
younger as compared to adult animals.  Consistently, 
studies with DOMP have failed to reveal effects on 
prostate of adult animals (BAILEY; HERBERT, 1982). 
Härkönen (2003) has proposed a model in which 
either pituitary or locally produced PRL could 
be bound the PRL receptors located in prostate 
epithelium and, hence, to initiate signal paths that 
will induce specific gene targeting expression. Once 
the gene product is stimulated, it would be distributed 
to various places in epithelial cells, lumen or prostate 
stroma where they could attract or have an effect 
on inflammatory cells. PRL also could interact with 
prolactin receptors located in inflammatory cells. 
The possible influence of each of these factors on the 
present results will be evaluated in future experiments. 
Our results confirm literature data in regards to 
the role of PRL in inducing prostate inflammation. 
Moreover, we can conclude that young animals are 
more susceptible to the PRL action in respect to 
prostate inflammation. 
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